1. Adjuvant Therapy in Pancreatic Cancer

   • Helmut Oettle
   • Peter Neuhaus

   Current Opinion 14 September 2012 Pages: 2293 - 2310

   

2. Hormone Therapy for the Prevention of Bone Loss in Menopausal Women with Osteopenia

   • Mary H. Hohenhaus
   • Kelly A. McGarry
   • Nananda F. Col

   Current Opinion 14 September 2012 Pages: 2311 - 2321

   

3. Pathophysiology and Management of Opioid-Induced Pruritus

   • Arjunan Ganesh
   • Lynne G. Maxwell

   Therapy In Practice 14 September 2012 Pages: 2323 - 2333

   

4. Estrogen Receptor Modulators and Down Regulators

   • Christa K. Baumann
   • Monica Castiglione-Gertsch

   Review Article 14 September 2012 Pages: 2335 - 2353

   

5. Multidrug-Resistant Streptococcus pneumoniae Infections

   • Françoise Van Bambeke
   • René R. Reinert
   • Willy E. Peetermans

   Review Article 14 September 2012 Pages: 2355 - 2382

   

6. Salmeterol/Fluticasone Propionate

   • Gillian M. Keating
   • Paul L. McCormack

   Adis Drug Evaluation 14 September 2012 Pages: 2383 - 2405

   

7. Budesonide/Formoterol

   • Paul L. McCormack
   • Katherine A. Lyseng-Williamson

   Adis Drug Evaluation 14 September 2012 Pages: 2407 - 2431

   

8. Celecoxib

   • James E. Frampton
   • Gillian M. Keating

   Adis Drug Evaluation 14 September 2012 Pages: 2433 - 2474

   

9. Continuous-Use Ethinylestradiol/Levonorgestrel 20μg/90μg

   • Antona J. Wagstaff

   Adis Drug Profile 14 September 2012 Pages: 2475 - 2479

   

10. Continuous-Use Ethinylestradiol/Levonorgestrel 20µg/90µg as an Oral Contraceptive

    • Paula Bednarek

    Adis Drug Profile 14 September 2012 Pages: 2480 - 2480

11. Continuous-Use Ethinylestradiol/Levonorgestrel 20µg/90µg as an Oral Contraceptive

    • Camelia Davtyan

    Adis Drug Profile 14 September 2012 Pages: 2480 - 2481